USD 125.65
Price
0.00
(0.00%)
Day Change
|
|
---|
NBIX, the overall quality is very good (Quality = 85) and the timing to buy is ...(Sign In to See)...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Good
- Reason
-
Acceleration of ROE growth rate is below our criteria.
Acceleration of net profit margin growth rate is below our criteria
In details, quality factors are not quite good , financial health is not quite good , and ability to make profit is good , ...
Quality Factors |
|
55% |
In Recommendations? | Not in any sections |
Select Rate | 0.00 From 30 days period |
Watch Rate | 0.00 From 30 days period |
Social Score | 12 |
Magic Formula Rank by ROA |
1433
|
Magic Formula Rank by ROE |
1433
|
Magic Formula Rank by ROIC |
1208
|
Price | 125.65 |
PBV / Sector |
4.68 / 0.25
|
Earning Per Share | 3.74 |
PE / Sector |
33.60 / 26.62
|
PEG or PE/Growth / Sector |
0.30 / -51.13
GREAT
|
Average 1M Daily Value |
138.77 M
GREAT
|
Average 1W Daily Value |
146.39 M
GREAT
|
Timing Factors |
|
85% |
Financial Health |
|
52% |
Ability to Make Profit |
|
75% |
Return to Investors |
|
4% |
Registration Details |
Analyze Date | 2024-11-23 19:34:54 |
Symbol | NBIX |
Name | NEUROCRINE BIOSCIENCES INC |
Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
Market | NASDAQ |
Listed Shares | 101.25 M |
Par Value | N/A |
Calculated From | Quarter |
Sign | N/A |
Market Cap (M.USD) / Sector Average | 12,721.69 / 10,062.04 |
News, Concensus, ... |
Estimation Consensus | See at WSJ.com |
Full details | See at WSJ.com |
Chart | See in Chart feature |
News | See at Yahoo Finance |